AI-powered drug discovery: update (V)
AI Drug Discovery companies with assets in preclinical and clinical trials
This newsletter is part of a series of newsletters dedicated to AI-drug discovery progress of drug candidates in preclinical and clinical phases. For the previous newsletters: